EXHIBIT 10.24 * AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 7, 2001 INFORMATION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE SEC. MASTER LABORATORY SERVICES AGREEMENT...Master Laboratory Services Agreement • December 7th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.16 MASTER LABORATORY SERVICES AGREEMENT THIS MASTER LABORATORY SERVICES AGREEMENT ("Agreement"), dated the 22nd day of March 1999, when signed by both parties, will set forth the terms and conditions between ADVANCED LIFE SCIENCES, an...Master Laboratory Services Agreement • June 16th, 2000 • Medichem Life Sciences Inc • Illinois
Addendum to MSA Center of Excellence EXECUTION COPY 6/21/2012Master Laboratory Services Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)
This Addendum is subject to the Master Laboratory Services Agreement effective as November 29, 2010 (“MSA”) between Eli Lilly and Company, an Indiana corporation (“Lilly”), and Cellular Dynamics International Inc., having its principal place of business at University Research Park, 525 Science Drive, Suite 200, Madison, WI 53711 ("CDI") and is made as of the date signed below, and shall be deemed a “Work Order” under the MSA.
AMENDMENT #1 To The MASTER LABORATORY SERVICES AGREEMENTMaster Laboratory Services Agreement • September 4th, 2012 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AMENDMENT (“Amendment”) is made as of October 28, 2011 (the “Effective Date”) by and between INTERCEPT PHARMACEUTALS, INC., whose address is 18 Desbrosses Street, New York, NY 10013 (“Sponsor”) and WIL RESEARCH LABORATORIES LLC, a Delaware limited liability company, with a principal place of business at 1407 George Road, Ashland, OH 44805 (“WIL”).
MASTER LABORATORY SERVICES AGREEMENTMaster Laboratory Services Agreement • November 10th, 2020 • Silverback Therapeutics, Inc. • Pharmaceutical preparations • New York
This Master Laboratory Services Agreement (“Agreement”), when signed by the parties, will set forth the terms and conditions between Silverback Therapeutics, Inc., with its principal offices located at 500 Fairview Avenue North, Suite 600, Seattle, WA 98109, United States (“Customer”) and Q Squared Solutions LLC, with its principal offices located at 5827 South Miami Blvd, Morrisville, NC 27560, USA (“Q Squared”), under which Q Squared agrees to provide laboratory services to Customer as set forth below.
MASTER LABORATORY SERVICES AGREEMENTMaster Laboratory Services Agreement • September 18th, 2006 • Tenby Pharma Inc • Blank checks • North Carolina
This Master Laboratory Services Agreement (“Agreement”), when signed by both parties, will set forth the terms and conditions between Rx DEVELOPMENT RESOURCES, a Florida corporation with its principal offices located at 3104 Cherry Palm Drive, Suite 260, Tampa, Florida 33619 (“Sponsor”) and QUINTILES LABORATORIES LIMITED, a North Carolina corporation with its principal offices located at 5500 Highlands Parkway, Suite 600, Smyrna, Georgia 30082 (“QLAB”), under which QLAB agrees to provide laboratory services to Sponsor as set forth below.
Master Laboratory Services AgreementMaster Laboratory Services Agreement • November 3rd, 2014 • Prana Biotechnology LTD • Pharmaceutical preparations • Ohio
This Master Laboratory Services Agreement (the “Agreement,”) dated as of 26 August, 2013 is by and between Prana Biotechnology Ltd ACN 080 699 065, an Australian limited liability company whose address is Level 2, 369 Royal Parade, Parkville Victoria 3052 (“Sponsor”) and WIL Research Laboratories, LLC (together with its subsidiaries), a Delaware limited liability company, whose address is 1407 George Road, Ashland, Ohio 44805 (hereinafter collectively referred to as “WIL”).
